Intravascular and diffuse dermal reactive angioendotheliomatosis secondary to iatrogenic arteriovenous fistulas

Journal of Cutaneous Pathology

Volumn 26, Issue 3, 1999, Pages 159-164

  Requena, Luis ^a,d   Fariña, Ma Carmen ^a   Renedo, Guadalupe ^a   Alvarez, Ana ^b   Sánchez Yus, Evaristo ^b   Sangueza, Omar P ^c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d C/Leopoldo Alas Clarin 4 3D   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; VASCULOTROPIN;

ADULT; AGED; ANGIOENDOTHELIOMATOSIS; ARTERIOVENOUS FISTULA; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; ENDOTHELIUM CELL; FEMALE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; MALE;

EID: 0032950685     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1999.tb01822.x     Document Type: Article

References (21)

1. 1. Bhawan J. Angioendotheliomatosis proliferans systemisata. An angiotropic neoplasm of lymphoid origin. Semin Diag Pathol 1987; 4: 18.
2. 2. Wick MR, Rocamora A. Reactive and malignant "angioendotheliomatosis"; a discriminant clinicopathologic study. J Cutan Pathol 1988; 15: 260.
3. 3. Pasyk K, Depowski M. Proliferating systematized angioendotheliomatosis of a 5-month old infant. Arch Dermatol 1978; 144: 1512.
4. 4. Ruiter M, Mandema E. New cutaneous syndrome in subacute bacterial endocarditis. Arch Intern Med 1964; 133: 175.
5. 5. Gupta AK, Lipa M, Haberman HF. Proliferating angioendotheliomatosis. Arch Dermatol 1986; 122: 314.
6. 6. Person JR. Systemic angioendotheliomatosis: a possible disorder of circulating angiogenic factor. Br J Dermatol 1977; 96: 329.
7. 7. LeBoit PE, Solomon AR, Santa Cruz DJ, Wick MR. Angiomatosis with luminal cryoprotein deposition. J Am Acad Dermatol 1992; 27: 969.
8. 8. Quinn TR, Alora MB, Momtaz KT, Taylor CR. Reactive angioendotheliomatosis with underlying hepatopathy and hypertensive portal gastropathy. Int J Dermatol 1998; 37: 382.
9. 9. Martin S, Pitcher D, Tschen J, Wolf JE. Reactive angioendotheliomatosis. J Am Acad Dermatol 1980; 2: 117.
10. 10. Lazova R, Slater C, Scott G. Reactive angioendotheliomatosis. Case report and review of the literature. Am J Dermatopathol 1996; 18: 63.
11. 11. Krell JM, Sanchez RL, Solomon AR. Diffuse dermal angiomatosis: a variant of reactive cutaneous angioendotheliomatosis. J Cutan Pathol 1994; 21: 363.
12. 12. Chandon JP, Gamby T, Bonerandi JJ, Monges A, Privat Y. Pseudomaladie de Kaposi (type Stewart-Bluefarb) après création d'une fistule artérioveineuse pour épuration extra-rénale. Bull Soc Fr Dermatol Syph 1975; 82: 363.
13. 13. Headley JL, Cole GW. The development of pseudo-Kaposi's sarcoma after placement of a vascular access graft. Br J Dermatol 1980; 102: 327.
14. 14. Goldbum OM, Krauss E, Bronner AK. Pseudo-Kaposi's sarcoma of the hand associated with an acquired, iatrogenic arteriovenous fistule. Arch Dermatol 1985; 121: 1038.
15. 15. Landthaler M, Stolz W, Eckert F, Schmoeckel C, Braun-Falco O. Pseudo-Kaposi's sarcoma ocurring after placement of arteriovenous shunt. A case report with DNA content analysis. J Am Acad Dermatol 1989; 21: 499.
16. 16. Mali JWH, Kuiper JT, Hamers AA. Acro-angiodermatitis of the foot. Arch Dermatol 1965; 92: 515.
17. 17. Bluefarb SM, Adams LA. Arteriovenous malformation with angiodermatitis: stasis dermatitis simulating Kaposi's disease. Arch Dermatol 1967; 96: 176.
18. 18. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029.
19. 19. Ferrara N. Vascular endothelial growth factor. Eur J Cancer 1996; 32A: 2413.
20. 20. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of vascular endotholial growth factor expression induced by myocardial ischaemia. Implications for coronary angiogenesis. Cardiovasc Res 1994; 24: 1176.
21. 21. Peer J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995; 72: 638.